Vishnu Chemicals Forms 6,000-Tonne Chromium Metal Joint Venture
Key highlights
- Vishnu Chemicals reported Q2 FY27 EBITDA of ₹64 crore, up 10% year on year.
- Vishnu Chemicals said Q2 FY27 revenue increased 7% year on year.
- The DCX Chrome SAS partnership is a 50:50 joint venture for a 6,000-tonne chromium metal facility.
- Vishnu Chemicals acquired Jayansree Pharma at an enterprise value of ₹52 crore in 2024.
powered by IRIS

Vishnu Chemicals Limited formed a 50:50 joint venture with France-based DCX Chrome SAS for a 6,000-tonne chromium metal facility, while its Q2 FY27 EBITDA rose 10% year on year to ₹64 crore. The announcement combines a new specialty-chemicals initiative with continued operating growth in the reported quarter.
Know Vishnu Chemicals inside out
Results, valuation, peers and who's buying, in one view.
What did Vishnu Chemicals announce in Q2 FY27?
Vishnu Chemicals announced on 10 November that it had entered into a 50:50 joint venture with DCX Chrome SAS. The partnership is intended to establish a chromium metal facility with a capacity of 6,000 tonnes. The company disclosed the development alongside its Q2 FY27 earnings release.
The proposed facility is focused on high-purity chromium metal, a product used in applications including aerospace and defence, according to the company information provided. The announcement does not disclose the investment amount, project location, commissioning schedule, expected sales contribution, or the financing structure for the venture.
The joint venture brings together Vishnu Chemicals, a Hyderabad-based manufacturer of inorganic specialty chemicals, and DCX Chrome SAS in France. The equal ownership structure means both partners will hold 50% stakes in the venture. No further details on governance arrangements or supply agreements were disclosed in the material provided.
How did Vishnu Chemicals perform in the quarter?
Vishnu Chemicals reported Q2 FY27 EBITDA of ₹64 crore, up 10% from the corresponding quarter a year earlier. Revenue increased 7% year on year, although the company did not provide the revenue value in the supplied information.
The growth figures indicate that operating profit rose faster than revenue during the period. However, the available disclosures do not provide EBITDA margin, net profit, volume growth, product-wise sales, pricing trends, raw-material costs, or segment-level financial data. As a result, the specific drivers of the quarterly increase cannot be determined from the reported data.
For investors tracking specialty chemicals, the quarterly update is relevant because it pairs reported operating progress with a new manufacturing initiative. The earnings figures are historical quarterly results, while the chromium-metal facility remains an announced project with key execution details yet to be disclosed.
Why is chromium metal important to Vishnu Chemicals' strategy?
The chromium metal venture adds a high-purity product initiative to Vishnu Chemicals' existing inorganic-chemicals business. The company supplies chemicals to industries including steel, glass, pharmaceuticals, pigments, dyes and leather. Its products also have applications such as corrosion protection, ceramics and pharmaceutical processes.
High-purity chromium metal has identified end uses in aerospace and defence. This positions the proposed facility in a more specialised part of the chromium value chain than bulk commodity materials. Still, the source does not specify the expected product grade, customer base, export plans, or domestic-market allocation for the new capacity.
The venture also follows other disclosed steps by Vishnu Chemicals to broaden its inorganic-chemicals footprint. The company completed the acquisition of Jayansree Pharma Private Limited on 30 November 2024 as part of its entry into strontium-based chemistry. The acquisition was completed at an enterprise value of ₹52 crore and added a gross block of ₹80 crore and a net block of ₹50 crore, according to the supplied company details.
Got a follow-up? Ask IRIS
What is the link with Vishnu Chemicals' South African mining acquisition?
Vishnu Chemicals had earlier signed definitive agreements, through its wholly owned subsidiary Vishnu South Africa (Pty) Limited, to acquire a chrome mining complex from the Volclay Group of Companies in South Africa. The transaction covered a chrome mine along with processing, mining and infrastructure assets in a combination of share and asset purchases.
The company had initially indicated that operations were expected to commence in Q1 FY27 after the transfer and transition process. In a later disclosure referring to the 9 November 2024 agreement, it said completion that had been expected within a year was proposed by January 2026. The supplied material does not state whether output from the mining complex will be used by the new DCX Chrome joint venture.
The mine acquisition and the chromium-metal venture nevertheless show activity across different parts of the chromium-related value chain. Investors should distinguish between these announcements because they involve different assets, locations and transaction structures. No combined capacity, production plan or financial contribution from these initiatives has been disclosed.
How could the announcement affect investors and industry operations?
For investors, the immediate confirmed information is the Q2 FY27 EBITDA increase to ₹64 crore, 7% revenue growth and the formation of the equal joint venture. These facts provide evidence of current-quarter operating performance and management's stated expansion direction, but they do not establish the future earnings contribution of the 6,000-tonne facility.
For industry participants, the project signals an effort to create chromium metal capacity serving specialised applications. Its eventual effect on customers, suppliers and competing producers will depend on construction, commissioning, product qualification and commercial arrangements that have not been disclosed. The available information does not report an announced change in prices, customer contracts or employment.
The broader context is Vishnu Chemicals' continued use of acquisitions and partnerships to expand its portfolio. Its purchase of Jayansree Pharma added strontium chemistry, while the South African transaction involved chrome mining assets. The DCX Chrome partnership is a separate step into chromium metal manufacturing and should be assessed on disclosed milestones rather than assumed synergies.
Conclusion
Vishnu Chemicals has combined a 10% year-on-year rise in Q2 FY27 EBITDA to ₹64 crore with a 50:50 partnership to develop a 6,000-tonne chromium metal facility. The update is significant because it places a reported improvement in operating performance alongside a move towards high-purity chromium products used in aerospace and defence applications.
The next disclosures to watch are the facility's location, capital expenditure, commissioning timetable, product specifications and expected commercial contribution. Investors may also monitor progress on the South African chrome mining complex, for which the company previously indicated a proposed completion timeline of January 2026.


